ABBOTT LABORATORIES — Director's Dealing 2023

Jun 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2023-06-16

Reporting Person: Boudreau Philip P (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-16	Common shares without par value	S	8000	$106	Disposed	15447	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	347	Indirect

Footnotes

F1: The sale transaction was made pursuant to a Rule 10b5-1(c) plan adopted on February 24, 2023.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of June 16, 2023.